Rotavirus Infection Therapeutics Market - Global Outlook and Forecast 2024-2031

Report ID: 1377100 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Rotavirus Infection Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Rotavirus Infection Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Rotavirus Infection Therapeutics Overall Market Size
    2.1 Global Rotavirus Infection Therapeutics Market Size: 2021 VS 2028
    2.2 Global Rotavirus Infection Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Rotavirus Infection Therapeutics Players in Global Market
    3.2 Top Global Rotavirus Infection Therapeutics Companies Ranked by Revenue
    3.3 Global Rotavirus Infection Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Rotavirus Infection Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Rotavirus Infection Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Rotavirus Infection Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Rotavirus Infection Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Rotavirus Infection Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Oral Drug
        4.1.3 Injiectable Drug
    4.2 By Type - Global Rotavirus Infection Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Rotavirus Infection Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Rotavirus Infection Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Rotavirus Infection Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Rotavirus Infection Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Rotavirus Infection Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Rotavirus Infection Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Rotavirus Infection Therapeutics Revenue, 2017-2028
        6.3.2 US Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.3.3 Canada Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Rotavirus Infection Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Rotavirus Infection Therapeutics Revenue, 2017-2028
        6.4.2 Germany Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.3 France Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.5 Italy Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.6 Russia Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Rotavirus Infection Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Rotavirus Infection Therapeutics Revenue, 2017-2028
        6.5.2 China Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.5.3 Japan Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.5.6 India Rotavirus Infection Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Rotavirus Infection Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Rotavirus Infection Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.7.3 Israel Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Rotavirus Infection Therapeutics Market Size, 2017-2028
        6.7.5 UAE Rotavirus Infection Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Corporate Summary
        7.1.2 GlaxoSmithKline Business Overview
        7.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Major Product Offerings
        7.1.4 GlaxoSmithKline Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 GlaxoSmithKline Key News
    7.2 Bharat Biotech
        7.2.1 Bharat Biotech Corporate Summary
        7.2.2 Bharat Biotech Business Overview
        7.2.3 Bharat Biotech Rotavirus Infection Therapeutics Major Product Offerings
        7.2.4 Bharat Biotech Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Bharat Biotech Key News
    7.3 Curevac
        7.3.1 Curevac Corporate Summary
        7.3.2 Curevac Business Overview
        7.3.3 Curevac Rotavirus Infection Therapeutics Major Product Offerings
        7.3.4 Curevac Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Curevac Key News
    7.4 Ology Bioservices
        7.4.1 Ology Bioservices Corporate Summary
        7.4.2 Ology Bioservices Business Overview
        7.4.3 Ology Bioservices Rotavirus Infection Therapeutics Major Product Offerings
        7.4.4 Ology Bioservices Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Ology Bioservices Key News
    7.5 BioKangtai
        7.5.1 BioKangtai Corporate Summary
        7.5.2 BioKangtai Business Overview
        7.5.3 BioKangtai Rotavirus Infection Therapeutics Major Product Offerings
        7.5.4 BioKangtai Rotavirus Infection Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 BioKangtai Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Rotavirus Infection Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Rotavirus Infection Therapeutics Market Drivers in Global Market
    Table 3. Rotavirus Infection Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Rotavirus Infection Therapeutics in Global Market
    Table 5. Top Rotavirus Infection Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Rotavirus Infection Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Rotavirus Infection Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Rotavirus Infection Therapeutics Product Type
    Table 9. List of Global Tier 1 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Rotavirus Infection Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Rotavirus Infection Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Rotavirus Infection Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. GlaxoSmithKline Corporate Summary
    Table 31. GlaxoSmithKline Rotavirus Infection Therapeutics Product Offerings
    Table 32. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Bharat Biotech Corporate Summary
    Table 34. Bharat Biotech Rotavirus Infection Therapeutics Product Offerings
    Table 35. Bharat Biotech Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Curevac Corporate Summary
    Table 37. Curevac Rotavirus Infection Therapeutics Product Offerings
    Table 38. Curevac Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Ology Bioservices Corporate Summary
    Table 40. Ology Bioservices Rotavirus Infection Therapeutics Product Offerings
    Table 41. Ology Bioservices Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. BioKangtai Corporate Summary
    Table 43. BioKangtai Rotavirus Infection Therapeutics Product Offerings
    Table 44. BioKangtai Rotavirus Infection Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Rotavirus Infection Therapeutics Segment by Type in 2021
    Figure 2. Rotavirus Infection Therapeutics Segment by Application in 2021
    Figure 3. Global Rotavirus Infection Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Rotavirus Infection Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Rotavirus Infection Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2021
    Figure 8. By Type - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Rotavirus Infection Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Rotavirus Infection Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. GlaxoSmithKline Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bharat Biotech Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Curevac Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Ology Bioservices Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. BioKangtai Rotavirus Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Rotavirus Infection Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rotavirus Infection Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rotavirus Infection Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Syphilis Diagnosis Market

Syphilis is a chronic, systemic sexually transmitted disease caused by the leptospira. Read More